Evidence map›Paper›PMID 26423385›Full record

ArticleThe American journal of clinical nutrition2015

Standardizing 25-hydroxyvitamin D values from the Canadian Health Measures Survey.

Kurtis Sarafin, Ramón Durazo-Arvizu, Lu Tian, Karen W Phinney, Susan Tai, Johanna E Camara, Joyce Merkel, Evan Green, Christopher T Sempos, Stephen P J Brooks

Abstract read
In one paragraph

Article in The American journal of clinical nutrition, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Rethinking vitamin D supplementation in calcium stone formers.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Vitamin D affects antiphospholipid syndrome by regulating T cells (Review).International journal of molecular medicine · 2025
    Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kurtis SarafinBureau of Nutritional Sciences, Health Canada, Ottawa, Canada;
Ramón Durazo-ArvizuDepartment of Public Health Sciences, Loyola University of Chicago Stritch School of Medicine, Chicago, IL;
Lu TianDepartment of Health Research and Policy, Stanford University School of Medicine, Palo Alto, CA;
Karen W PhinneyBiomolecular Measurement Division and.
Susan TaiChemical Sciences Division, National Institute of Standards and Technology, Gaithersburg, MD;
Johanna E CamaraChemical Sciences Division, National Institute of Standards and Technology, Gaithersburg, MD;
Joyce MerkelNIH, Office of Dietary Supplements, Bethesda, MD; and.
Evan GreenStatistics Canada, Ottawa, Canada.
Christopher T SemposNIH, Office of Dietary Supplements, Bethesda, MD; and.
Stephen P J BrooksBureau of Nutritional Sciences, Health Canada, Ottawa, Canada; steve.brooks@hc-sc.gc.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Canadian Health Measures Survey (CHMS) is an ongoing cross-sectional national survey that includes a measure of 25-hydroxyvitamin D [25(OH)D] by immunoassay. For cycles 1 and 2, the collection period occurred approximately every 2 y, with a new sample of ∼5600 individuals.

objectiveThe goal was to standardize the original 25(OH)D CHMS values in cycles 1 and 2 to the internationally recognized reference measurement procedures (RMPs) developed by the US National Institute for Standards and Technology (NIST) and Ghent University, Belgium.

designStandardization was accomplished by using a 2-step procedure. First, serum samples corresponding to the original plasma samples were remeasured by using the currently available immunoassay method. Second, 50 serum samples with known 25(OH)D values assigned by the NIST and Ghent reference method laboratories were measured by using the currently available immunoassay method. The mathematical models for each step-i.e., 1) YCurrent = XOriginal and 2) YNIST-Ghent = XCurrent -were estimated by using Deming regression, and the 2 models were solved to obtain a single equation for converting the "original" values to NIST-Ghent RMP values.

resultsAfter standardization (cycles 1 and 2 combined), the percentage of Canadians with 25(OH)D values <40 nmol/L increased from 16.4% (original) to 19.4% (standardized), and values <50 nmol/L increased from 29.0% (original) to 36.8% (standardized). The 25(OH)D standardized distributions (cycles 1 and 2 analyzed separately) were similar across age and sex groups; slightly higher values were associated with cycle 2 in the young and old. This finding contrasts with the original data, which indicated that cycle 2 values were lower for all age groups.

conclusionThe shifts in 25(OH)D distribution brought about by standardization indicate its importance in drawing correct conclusions about potential population deficiencies and insufficiencies and in permitting the comparison of distributions between national surveys.

Indexed as

Models, StatisticalNutrition Assessment25-Hydroxyvitamin D 2AdolescentAdultAgedAutomation, LaboratoryCalcifediolCanadaChildCross-Sectional StudiesEarly DiagnosisFemaleHumansImmunoassayMale25-Hydroxyvitamin D 2CalcifedioladequacyCHMSimmunoassaypopulation surveystandardizationvitamin D

Identifiers

PMID26423385
PMCPMC4625585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.